Conserved regression patterns of retinopathy of prematurity after intravitreal ranibizumab: A class effect.
Marco H JiDarius M MoshfeghiRyan A ShieldsZachary BodnarCassie A LudwigNatalia F CallawayLorenzo OraziGiulia M AmorelliDomenico LeporePublished in: European journal of ophthalmology (2020)
IVR conforms to the previously described regression patterns following intravitreal bevacizumab for ROP indicative of a class effect. Follow-up using FA might help to optimize the management of these infants after injection of the drug.